Related Experiment Video
Updated: Jun 4, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Non-AIDS-Defining Malignancies in Patients with HIV in the HAART Era
Minh Ly Nguyen1, Kevin James Farrell, Clifford James Gunthel
1Emory University School of Medicine, 341 Ponce de Leon NE, Atlanta, GA, 30308, USA, mnguye3@emory.edu.
Insights
Highly active antiretroviral therapy (HAART) has shifted HIV disease from AIDS-related to non-AIDS-defining malignancies (NADM). NADM, particularly infection-related cancers, are increasing in HIV patients, necessitating better cancer screening and research.
Area of Science:
- Oncology
- Infectious Diseases
- Public Health
Background:
- Highly active antiretroviral therapy (HAART) has transformed HIV/AIDS care, reducing AIDS-defining illnesses.
- A shift in disease spectrum is observed, with a decrease in AIDS-related cancers and an increase in non-AIDS-defining malignancies (NADM).
Purpose of the Study:
- To review the causes, clinical presentation, pathology, and treatment outcomes of common NADMs in the HAART era.
- To analyze the incidence of NADM in HIV-infected individuals compared to the general population.
Main Methods:
- Review of published studies and meta-analysis of data linking HIV/AIDS databases with cancer registries.
- Focus on four prevalent NADMs during the HAART era.
Main Results:
- A significant increase in NADM incidence among HIV-infected individuals compared to the general population.
- Infection-related cancers (anal, Hodgkin lymphoma, liver) and non-infection-related cancers (lung, skin) are predominant NADMs.
- The overall impact of HAART on NADM outcomes remains unclear.
Conclusions:
- HIV-infected individuals are experiencing a rise in NADMs, particularly infection-related cancers.
- Enhanced cancer screening strategies are crucial for early detection in the aging HIV-positive population.
- Further prospective studies are required to fully understand HAART's effect on cancer outcomes in HIV patients.
Abstract:
The introduction of highly active antiretroviral therapy (HAART) has drastically changed the scope and spectrum of diseases associated with HIV, shifting from AIDS-related to non-AIDS-related diseases. Studies linking HIV/AIDS databases to cancer registries have shown a dramatic decrease in AIDS-related malignancies and a steady increase in non-AIDS-defining malignancies (NADM). We review the causes underlying the rise in incidence of NADM and the clinical presentation, pathology, and treatment outcomes of the four most commonly encountered NADM in the HAART era. Meta-analysis of published studies show an increase in NADM over the general population, mostly among infection-related cancers such as anal cancer, Hodgkin lymphoma, and liver cancer. Among the non-infection-related cancers, lung and skin cancers predominate. The overall effect of HAART on NADM is unsettled. As HIV-infected individuals survive longer, better screening strategies are needed to detect cancer earlier, and prospective data are needed to assess the impact of HAART on cancer outcomes.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cryptococcal Meningitis
Mechanisms of Retrovirus-induced Cancers
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
